FASB reopens goodwill: what the impairment testing changes mean
The board is revisiting where and how often goodwill gets tested, and a shift to trigger-based testing at a higher unit level would hand finance teams a controls project, not a workload cut.
FASB has put goodwill back on its technical agenda, and the goodwill impairment testing changes under consideration hit the two variables that drive the most finance-team hours: where the test happens and how often it has to happen. CFO Dive reported on July 29, 2026 that the board voted to add the project, roughly four years after abandoning an earlier effort that explored amortization. Accounting Today confirmed on August 3 that the scope covers both the level of testing and its frequency. This is the window in which reporting-unit structure decisions get made.
What FASB actually put back on the agenda
The project is narrower than the one the board removed in June 2022, but it targets the mechanics that matter operationally. Eliminating the required annual test drew support from several board members, including the vice chair, according to CFO Dive's July report. Testing at a level above the reporting unit, such as the entity or the operating segment, is the other half of the file.
The board has not committed to a model. FASB staff previously laid out five possible paths, including required amortization after initial recognition, extending the Private Company Council amortization alternative to all entities, an option to write goodwill off after initial recognition, and enhanced disclosures without a measurement change. FASB Chair Richard Jones has publicly described the existing model as a compromise, which is a fair reading of a regime that pairs a qualitative screen with a quantitative fair value test.
The topic is live internationally too. FASB and the IASB held a joint education session on goodwill in June 2026. In the agenda paper for that session, stakeholders who ranked goodwill a low priority warned that the board risks running into the same obstacles that killed the last project, and noted that goodwill valuations are getting more complex and more expensive to produce.
Trigger-only testing is a controls project, not a workload cut
Dropping the annual test reads as relief on first pass. In practice it moves the burden from a scheduled valuation exercise to a continuous monitoring obligation. Someone has to own a documented, repeatable process for identifying triggering events between reporting dates, with evidence an auditor will accept and quarterly memos explaining why no test was performed. Negative evidence is harder to document than positive evidence.
That lands on close processes that are already strained. RSM cites 7% of 2025 10-K filings disclosing at least one material weakness. A judgment-heavy assessment performed four times a year, largely by exception, is exactly the kind of control that fails on documentation rather than on conclusion. Finance leaders who currently outsource the annual valuation to a third party will find that the trigger assessment is not outsourceable in the same way.
Practical build items: a defined list of internal and external indicators tied to owned data sources, a threshold policy for when an indicator escalates to a quantitative test, named owners in FP&A and controllership, and a standing quarterly memo template reviewed by the audit committee.
A higher-level test changes outcomes, not just process
Testing at the entity or segment level is not a neutral simplification. Aggregation lets strong units absorb weak ones, which mechanically reduces the frequency and size of impairments. That is a benefit to reported earnings and a red flag to investors and analysts who use impairment as a signal on acquisition discipline.
It also interacts with segment reporting. If goodwill is tested at a level that no longer maps to how the chief operating decision maker reviews results, expect questions from auditors and from the SEC staff on consistency between the impairment unit and the segment disclosures now expanded under the segment expense standard. Companies that have been carrying goodwill allocated to small, underperforming reporting units should model what happens to that carrying value under aggregation before assuming relief.
If amortization returns, the repricing is broader than EPS
Amortization remains on the staff's list of paths even though it is not the stated focus of the current project. If it comes back in any form, the effects run past the income statement. Covenant headroom on tangible net worth tests and earnings-based ratios changes. Purchase price allocations get repriced, because the incentive to push value toward indefinite-lived goodwill and away from finite-lived intangibles inverts. Management incentive plans tied to GAAP earnings need review.
None of that argues for waiting. It argues for modeling both futures now: a trigger-based, higher-level regime and an amortization regime, using the current goodwill balance and acquisition pipeline. Deals signed in 2026 and 2027 will sit under whatever model emerges.
What to do while the scope is still open
Do not restructure reporting units during the 2026 close purely for administrative convenience. A reorganization that looks efficient under today's annual test can strand carrying value or create a required interim test under a revised model, and reallocations invite scrutiny when they conveniently avoid an impairment.
Comment-and-deliberate season is the only period in which preparer input changes scope. Companies with concentrated goodwill balances, frequent tuck-in acquisitions, or private-company subsidiaries applying the PCC alternative have specific evidence the board needs. A short, fact-based comment letter describing actual cost and actual judgment exposure carries more weight than a general preference.
In the meantime, keep the current process intact. The annual test is still required, the qualitative screen still applies, and an unchanged standard is the base case until the board issues an exposure draft.
Key takeaways
- FASB's new goodwill project covers both the level at which goodwill is tested and how often, roughly four years after the board dropped an earlier amortization effort.
- Trigger-based testing replaces a scheduled valuation with a quarterly monitoring control, including documented memos explaining why no test was performed.
- Testing at the entity or segment level reduces impairment frequency by letting strong units offset weak ones, which raises investor and segment-disclosure questions.
- RSM cites 7% of 2025 10-K filings disclosing at least one material weakness, so new judgment-heavy assessments land on already strained close processes.
- Avoid reorganizing reporting units during the 2026 close, model an amortization scenario for covenant and EPS effects, and file a comment letter while scope is open.
